SIRT1 and hepatocellular carcinoma: In support of their findings, Zhang et al. [129] demonstrate that activated SIRT1 with phosphorylation at S47 serves as a prognostic factor for a longer relapse-free survival (RFS) in patients with hepatocellular carcinoma (HCC) carrying mutp53.